IL185024D0 - Raf inhibitor compounds and methods - Google Patents

Raf inhibitor compounds and methods

Info

Publication number
IL185024D0
IL185024D0 IL18502407A IL18502407A IL185024D0 IL 185024 D0 IL185024 D0 IL 185024D0 IL 18502407 A IL18502407 A IL 18502407A IL 18502407 A IL18502407 A IL 18502407A IL 185024 D0 IL185024 D0 IL 185024D0
Authority
IL
Israel
Prior art keywords
methods
inhibitor compounds
raf inhibitor
raf
compounds
Prior art date
Application number
IL18502407A
Original Assignee
Genentech Inc
Array Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US65005005P priority Critical
Priority to PCT/US2006/003654 priority patent/WO2006084015A2/en
Application filed by Genentech Inc, Array Biopharma Inc filed Critical Genentech Inc
Publication of IL185024D0 publication Critical patent/IL185024D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
IL18502407A 2005-02-04 2007-08-02 Raf inhibitor compounds and methods IL185024D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US65005005P true 2005-02-04 2005-02-04
PCT/US2006/003654 WO2006084015A2 (en) 2005-02-04 2006-02-02 Raf inhibitor compounds and methods

Publications (1)

Publication Number Publication Date
IL185024D0 true IL185024D0 (en) 2007-12-03

Family

ID=36571626

Family Applications (1)

Application Number Title Priority Date Filing Date
IL18502407A IL185024D0 (en) 2005-02-04 2007-08-02 Raf inhibitor compounds and methods

Country Status (18)

Country Link
US (2) US7491829B2 (en)
EP (1) EP1846391A2 (en)
JP (1) JP2008530011A (en)
KR (1) KR20070107104A (en)
CN (1) CN101282960A (en)
AR (1) AR053014A1 (en)
AU (1) AU2006210626A1 (en)
BR (1) BRPI0607346A2 (en)
CA (1) CA2596973A1 (en)
CR (1) CR9365A (en)
IL (1) IL185024D0 (en)
MA (1) MA29310B1 (en)
MX (1) MX2007009405A (en)
NO (1) NO20074473L (en)
RU (1) RU2007133111A (en)
TW (1) TW200639163A (en)
WO (1) WO2006084015A2 (en)
ZA (1) ZA200707289B (en)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2057146A1 (en) 2006-10-02 2009-05-13 Irm Llc Compounds and compositions as protein kinase inhibitors
AU2007311026B2 (en) * 2006-10-17 2012-05-17 Stiefel Laboratories, Inc. Talarazole metabolites
CA2700327A1 (en) * 2007-09-20 2009-03-26 Wyeth Llc Pyrazolo[5, 1-c] [1,2,4] triazines, methods for preparation and use thereof
WO2009108827A1 (en) * 2008-02-29 2009-09-03 Wyeth Fused tricyclic pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof
AR072657A1 (en) * 2008-02-29 2010-09-15 Genentech Inc Raf inhibitor compounds and methods for use
CA2716949A1 (en) 2008-02-29 2009-09-11 Array Biopharma Inc. N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
CA2716947A1 (en) * 2008-02-29 2009-09-11 Array Biopharma Inc. Imidazo [4,5-b] pyridine derivatives used as raf inhibitors
WO2009111260A1 (en) * 2008-02-29 2009-09-11 Wyeth Phenylsulfonamide-substituted, pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof
WO2009111278A2 (en) * 2008-02-29 2009-09-11 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
JP2009286773A (en) * 2008-03-14 2009-12-10 Bayer Cropscience Ag Insecticidal condensed-ring aryl compounds
EA029131B1 (en) 2008-05-21 2018-02-28 Ариад Фармасьютикалз, Инк. Phosphorous derivatives as kinase inhibitors
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
EP2381777A4 (en) * 2008-12-12 2012-08-08 Ariad Pharma Inc Azaindole derivatives as kinase inhibitors
WO2010144909A1 (en) 2009-06-12 2010-12-16 Novartis Ag Fused heterocyclic compounds and their uses
CA2771893A1 (en) 2009-08-28 2011-03-03 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
SG178534A1 (en) 2009-08-28 2012-03-29 Array Biopharma Inc Raf inhibitor compounds and methods of use thereof
EP2470511A1 (en) * 2009-08-28 2012-07-04 Genentech, Inc. Raf inhibitor compounds and methods of use thereof
CA2771895A1 (en) 2009-08-28 2011-03-03 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
US20130018033A1 (en) 2009-08-28 2013-01-17 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
US20120157452A1 (en) 2009-08-28 2012-06-21 Genentech, Inc. 1h-pyrazolo[3,4-b] pyridine compounds for inhibiting raf kinase
CN102812014B (en) * 2009-10-30 2016-01-20 多美恩医疗公司 Novel oxime derivatives and their use as metabotropic glutamate receptor allosteric modulators
CA2784807A1 (en) 2009-12-29 2011-07-28 Dana-Farber Cancer Institute, Inc. Type ii raf kinase inhibitors
NZ601033A (en) 2009-12-31 2014-02-28 Ct Nac Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
US20120122928A1 (en) 2010-08-11 2012-05-17 Bayer Cropscience Ag Heteroarylpiperidine and -Piperazine Derivatives as Fungicides
US8759527B2 (en) 2010-08-25 2014-06-24 Bayer Cropscience Ag Heteroarylpiperidine and -piperazine derivatives as fungicides
EP2423210A1 (en) 2010-08-25 2012-02-29 Bayer CropScience AG Heteroarylpiperidine and heteroarylpiperazine derivatives as fungicides
CN103492379B (en) 2010-10-27 2018-06-15 拜耳知识产权有限责任公司 As fungicides piperidine heteroaryl and heteroaryl piperazine derivatives
CN103298808A (en) 2011-01-06 2013-09-11 加拿大贝达药业有限公司 Novel ureas for the treatment and prevention of cancer
WO2012098387A1 (en) 2011-01-18 2012-07-26 Centro Nacional De Investigaciones Oncológicas (Cnio) 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
MX352307B (en) 2011-02-01 2017-11-17 Bayer Ip Gmbh Heteroaryl piperidine and heteroaryl piperazine derivatives as fungicides.
WO2012145503A1 (en) 2011-04-21 2012-10-26 Novartis Ag Pharmaceutical combinations
EA201391626A1 (en) 2011-05-04 2014-03-31 Ариад Фармасьютикалз, Инк. Compounds for inhibiting cell proliferation in egfr-stimulated cancer types
CN103930111A (en) 2011-09-19 2014-07-16 霍夫曼-拉罗奇有限公司 Combination treatments comprising C-MET antagonists and B-RAF antagonists
WO2013074986A1 (en) 2011-11-17 2013-05-23 Dana-Farber Cancer Institute, Inc. Inhibitors of c-jun-n-terminal kinase (jnk)
US9408885B2 (en) 2011-12-01 2016-08-09 Vib Vzw Combinations of therapeutic agents for treating melanoma
WO2013098229A2 (en) 2011-12-27 2013-07-04 Bayer Intellectual Property Gmbh Heteroarylpiperidine and piperazine derivatives as fungicides
PL2797888T3 (en) * 2011-12-31 2016-12-30 Fused tricyclic compounds as raf kinase inhibitors
WO2013169401A1 (en) 2012-05-05 2013-11-14 Ariad Pharmaceuticals, Inc. Compounds for inhibiting cell proliferation in egfr-driven cancers
US10112927B2 (en) 2012-10-18 2018-10-30 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinase 7 (CDK7)
US10000483B2 (en) 2012-10-19 2018-06-19 Dana-Farber Cancer Institute, Inc. Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
US9758522B2 (en) 2012-10-19 2017-09-12 Dana-Farber Cancer Institute, Inc. Hydrophobically tagged small molecules as inducers of protein degradation
KR20150118159A (en) 2013-02-22 2015-10-21 에프. 호프만-라 로슈 아게 Methods of treating cancer and preventing drug resistance
TWI622396B (en) * 2013-03-14 2018-05-01 Lilly Co Eli Cdc7 inhibitors
BR112015023203A8 (en) 2013-03-15 2018-01-23 Constellation Pharmaceuticals Inc methods for the treatment of cancer, method for increasing the efficiency of a treatment of cancer, method for delaying and / or preventing the development of cancer, method for treating an individual with cancer, method for increasing the sensitivity to a therapy agent for cancer, method to extend a period of sensitivity and method to extend the duration of response to therapy for cancer.
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
EP3013797B1 (en) 2013-06-28 2018-01-03 BeiGene, Ltd. Fused tricyclic amide compounds as multiple kinase inhibitors
CA2924172A1 (en) 2013-09-13 2015-03-19 Beigene, Ltd. Anti-pd1 antibodies and their use as therapeutics and diagnostics
WO2015041533A1 (en) 2013-09-20 2015-03-26 Stichting Het Nederlands Kanker Instituut Rock in combination with mapk-pathway
WO2015041534A1 (en) 2013-09-20 2015-03-26 Stichting Het Nederlands Kanker Instituut P90rsk in combination with raf/erk/mek
EP3122900A1 (en) 2014-03-24 2017-02-01 F.Hoffmann-La Roche Ag Cancer treatment with c-met antagonists and correlation of the latter with hgf expression
US20170027940A1 (en) 2014-04-10 2017-02-02 Stichting Het Nederlands Kanker Instituut Method for treating cancer
WO2015164614A1 (en) 2014-04-23 2015-10-29 Dana-Farber Cancer Institute, Inc. Janus kinase inhibitors and uses thereof
WO2015164604A1 (en) 2014-04-23 2015-10-29 Dana-Farber Cancer Institute, Inc. Hydrophobically tagged janus kinase inhibitors and uses thereof
WO2015178770A1 (en) 2014-05-19 2015-11-26 Stichting Het Nederlands Kanker Instituut Compositions for cancer treatment
CN107073121A (en) 2014-06-13 2017-08-18 基因泰克公司 Methods of treating and preventing cancer drug resistance
WO2015196072A2 (en) * 2014-06-19 2015-12-23 Whitehead Institute For Biomedical Research Uses of kinase inhibitors for inducing and maintaining pluripotency
CA2954508A1 (en) 2014-07-15 2016-01-21 Genentech, Inc. Compositions for treating cancer using pd-1 axis binding antagonists and mek inhibitors
KR20170139073A (en) 2015-04-15 2017-12-18 베이진 엘티디 Maleate salt of the B-raf kinase inhibitor, crystalline forms, manufacturing method, and use thereof
AU2016355320A1 (en) 2015-11-19 2018-05-17 Genentech, Inc. Methods of treating cancer using B-RAF inhibitors and immune checkpoint inhibitors
WO2018146253A1 (en) 2017-02-10 2018-08-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the mapk pathway
WO2019133810A1 (en) 2017-12-28 2019-07-04 Tract Pharmaceuticals, Inc. Stem cell culture systems for columnar epithelial stem cells, and uses related thereto

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1245283A (en) 1968-10-04 1971-09-08 Labaz Pyrazole derivatives
JP2753659B2 (en) 1990-09-03 1998-05-20 株式会社大塚製薬工場 Pyrazole derivatives
US5356897A (en) 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
JPH05125079A (en) 1991-11-05 1993-05-21 Otsuka Pharmaceut Factory Inc Pyrazolo(1,5-a)pyrimidine derivative
US5707997A (en) 1994-06-21 1998-01-13 Otsuka Pharmaceutical Factory, Inc. Pyrazolo 1,5-a!pyrimidine derivative
US5486534A (en) 1994-07-21 1996-01-23 G. D. Searle & Co. 3,4-substituted pyrazoles for the treatment of inflammation
AU707530B2 (en) 1995-09-28 1999-07-15 Otsuka Pharmaceutical Factory, Inc. Analgesic composition
JPH10101672A (en) 1996-08-06 1998-04-21 Otsuka Pharmaceut Factory Inc Adenosine enhancer
JPH10101671A (en) 1996-08-08 1998-04-21 Otsuka Pharmaceut Factory Inc Nitrogen monoxide synthase inhibitor
US6514977B1 (en) 1997-05-22 2003-02-04 G.D. Searle & Company Substituted pyrazoles as p38 kinase inhibitors
CA2288741A1 (en) 1997-05-22 1998-11-26 G.D. Searle And Co. 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
JP2000153671A (en) 1998-11-20 2000-06-06 Fuji Photo Film Co Ltd Heat-sensitive recording material
JP2002542280A (en) 1999-04-27 2002-12-10 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Novel therapeutic
TWI271406B (en) 1999-12-13 2007-01-21 Eisai Co Ltd Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
AU782878B2 (en) 2000-02-05 2005-09-08 Vertex Pharmaceuticals Incorporated Pyrazole compositions useful as inhibitors of erk
EP1207864A2 (en) 2000-02-05 2002-05-29 Bemis, Guy Compositions useful as inhibitors of erk
JP4783532B2 (en) 2000-02-05 2011-09-28 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated Useful pyrazole compositions as inhibitors of Erk
JP2003525936A (en) 2000-03-06 2003-09-02 スミスクライン ビーチャム パブリック リミテッド カンパニー Imidazole derivatives as Raf kinase inhibitors
AU8790101A (en) 2000-09-21 2002-04-02 Smithkline Beecham Plc Imidazole derivatives as raf kinase inhibitors
AT526330T (en) 2000-12-28 2011-10-15 Ono Pharmaceutical Co Heterotrizyklische compounds as antagonists of CRF receptor
WO2002057265A1 (en) 2001-01-22 2002-07-25 Sankyo Company, Limited Compounds substituted with bicyclic amino groups
CA2440211A1 (en) * 2001-03-09 2002-09-19 Pfizer Products Inc. Benzimidazole anti-inflammatory compounds
JP4310109B2 (en) 2001-04-26 2009-08-05 エーザイ・アール・アンド・ディー・マネジメント株式会社 Nitrogen-containing fused ring compound having a pyrazolyl group as a substituent and pharmaceutical compositions thereof
GB0112348D0 (en) 2001-05-19 2001-07-11 Smithkline Beecham Plc Compounds
NZ528525A (en) 2001-05-24 2005-10-28 Lilly Co Eli Novel pyrrole derivatives as pharmaceutical agents
MXPA04001088A (en) 2001-08-03 2004-05-20 Vertex Pharma Pyrazole-derived kinase inhibitors and uses thereof.
EP1423382B1 (en) 2001-08-03 2008-04-16 Vertex Pharmaceuticals Incorporated Pyrazole-derived kinase inhibitors and uses thereof
GB0121490D0 (en) 2001-09-05 2001-10-24 Smithkline Beecham Plc Ciompounds
GB0121494D0 (en) 2001-09-05 2001-10-24 Smithkline Beecham Plc Compounds
US6897208B2 (en) 2001-10-26 2005-05-24 Aventis Pharmaceuticals Inc. Benzimidazoles
US20040010027A1 (en) * 2001-12-17 2004-01-15 Pharmacia & Upjohn Spa Hydroxphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical comositions comprising them
ES2295441T3 (en) * 2001-12-18 2008-04-16 MERCK & CO., INC. Modulators heteroaryl substituted pyrazole 5 metabotropic receptor glutamate.
US7247734B2 (en) 2001-12-21 2007-07-24 Vernalis (Cambridge) Limited 3,4-diarylpyrazoles and their use in the therapy of cancer
EP1504004B1 (en) 2002-05-10 2007-06-27 SmithKline Beecham Corporation Substituted pyrazolopyrimidines
GB0217786D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd Compounds
AU2003260345A1 (en) 2002-07-31 2004-02-23 Smithkline Beecham Corporation 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
AT343572T (en) * 2002-08-09 2006-11-15 Lilly Co Eli Benzimidazoles and benzothiazoles as inhibitors of kinase map
JP2006501263A (en) 2002-09-09 2006-01-12 アムジエン・インコーポレーテツド 1,4,5-substitution as TNF-alpha and interleukin-lowering agent for the treatment of inflammation 1,2-dihydro - pyrazol-3-one and 3-alkoxy -1H- pyrazole derivatives
US7365066B2 (en) * 2002-09-17 2008-04-29 Eli Lilly And Company Pyrazolopyridine derivatives as pharmaceutical agents
EP2165708A3 (en) 2002-09-18 2010-07-28 Pfizer Products Inc. New pyrazole derivatives as transforming growth factor (TGF) inhibitors
AU2003268155A1 (en) 2002-09-19 2004-04-08 Eli Lilly And Company Methods of inhibiting tgf beta with substituted pyrazoles
AU2003290734A1 (en) * 2002-11-27 2004-06-23 Eli Lilly And Company Novel compounds as pharmaceutical agents
US7176210B2 (en) 2003-02-10 2007-02-13 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
CL2004000234A1 (en) 2003-02-12 2005-04-15 Biogen Idec Inc Compounds derived 3- (pyridin-2-yl) -4-heteroaryl-substituted pyrazole, aik5 antagonists and / or aik4; pharmaceutical composition and use of the compound in the treatment of fibrotic disorders such as scleroderma, lupus nephritis, scarring of smite
GB0313915D0 (en) * 2003-06-16 2003-07-23 Smithkline Beecham Corp Compounds

Also Published As

Publication number Publication date
AU2006210626A1 (en) 2006-08-10
MX2007009405A (en) 2007-09-25
BRPI0607346A2 (en) 2009-09-01
CA2596973A1 (en) 2006-08-10
US20060189627A1 (en) 2006-08-24
JP2008530011A (en) 2008-08-07
EP1846391A2 (en) 2007-10-24
RU2007133111A (en) 2009-03-10
TW200639163A (en) 2006-11-16
CR9365A (en) 2008-01-15
ZA200707289B (en) 2009-09-30
MA29310B1 (en) 2008-03-03
US20090176809A1 (en) 2009-07-09
WO2006084015A2 (en) 2006-08-10
AR053014A1 (en) 2007-04-18
NO20074473L (en) 2007-10-31
CN101282960A (en) 2008-10-08
WO2006084015A3 (en) 2006-11-23
US7491829B2 (en) 2009-02-17
KR20070107104A (en) 2007-11-06

Similar Documents

Publication Publication Date Title
TWI441819B (en) Compounds for inflammation and immune-related uses
TWI422376B (en) Compounds for inflammation and immune-related uses
TWI377134B (en) Sicherheitsdokument
IL183278D0 (en) Rod-coupling assemblies
EP1789709A4 (en) Stopcock
PT2073008E (en) Improved immunoassay methods
EP1802588A4 (en) Substituted amino-pyrimidones and uses thereof
EP1883709A4 (en) Human micrornas and methods for inhibiting same
DE502006001600D1 (en) Pyrazolylcarboxanilide
DE602006018441D1 (en) Arabinofuranosidasen
DE602006017073D1 (en) Aspartylproteasehemmer
EP1736763A4 (en) Analyzer
GB0713202D0 (en) No title
PL385229A1 (en) The manners and indirect compounds
EP1910736A4 (en) Etendue-conserving illumination-optics for backlights and frontlights
EP1987397A4 (en) Writing apparatuses and methods
ZA200802585B (en) Pyridopyrimidinone inhibitors of Pl3Kα
IL186490D0 (en) Multicyclic compounds and methods of their use
SI1910348T1 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
IL185185D0 (en) Azolylacylguanidines as ??-secretase inhibitors
ZA200802867B (en) Fap inhibitors
EP1906945A4 (en) Hcv inhibitors
GB0516156D0 (en) JNK inhibitors
GB0502258D0 (en) Compounds and their use
DE602006016093D1 (en) Cyanoanthranilamidinsektizide